Note: Ingredients listed on restricted chemical lists
EC/CAS
111-76-2
Name of the chemical
Ethylene glycol monobutyl ether (EGBE)
Concentration
N/A
EC/CAS
68411-30-3
Name of the chemical
Benzenesulfonic acid,C10-13-alkyl derivs., sodium salts
Concentration
N/A
EC/CAS
203-905-0
Name of the chemical
Ethylene glycol monobutyl ether (EGBE)
Concentration
N/A
General Information
Revision date
2021-11-15
Product name
SANIGEN BIOFINSH
Icons in SDS
Company Information
company name
SUMINISTROS CIENTÍFICOS TÉCNICOS, S.A.U. (SUCITESA)
e-mail address of the competent person responsible for the Safety Data Sheet
info@sucitesa.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H315, H318
Hazard statements
Code
Statements
H315
Causes skin irritation
Section 2
CLP CLASSIFICATION
Skin Irrit. 2 H315 Eye Dam. 1 H318
2.2 Label elements
Label elements according to Regulation (EC) No 1272/2008 - CLP
Signal word
Danger
Hazard statements
H phrases) H315 Causes skin irritation H318 Causes serious eye damage
Precautionary statements
P phrases) Page Document: 04LAB004 Code: 800872 Trade name: SANIGEN® BIOFINSH Language: ENG Issue date 11/06/2021 Revision Date: 15/11/2021 Version: 2 In accordance with Regulation (EC) No. 1907/2006 (REACH) P102 Keep out of reach of children P280_13 Wear protective gloves and eye protection P302+P352 IF ON SKIN: Wash with plenty of soap and water P305+P351+P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing Additional information on the label Do not swallow
Contains
Benzenesulfonic acid, C10-13-alkyl derivs., sodium salts Preservatives: Tetramethylolglycoluril PROFESSIONAL USE
2.3 Other hazards
The product does not meet the classification criteria be considered PBT or vPvP, in accordance with Annex XIII of the REACH Regulation (EC) No 1907/2006. No other known hazards
